Gujarat Themis Biosyn's board approved a preferential issue of up to 82.11 lakh equity shares at Rs. 408 each, aiming to raise Rs. 335.00 crore.

GT

Gujarat Themis Biosyn LimitedGUJTHEM · Filed with the exchange

This capital infusion is subject to shareholder approval.

No comments yet. Be the first.

More from Gujarat Themis Biosyn Limited

Free

Join 5,000+ investors following the market on Alpha Tribe.

Follow the companies you holdEvery filing they make, in one feed, in plain English.
Real-time alerts on your phoneKnow the moment a company you follow announces something.
Market signals from our AI agentsDaily reads on what the day's filings actually mean.

No card needed. Takes about a minute.